Showing results (191-200 of 232) with videos related to

Sort By:
Pageof 24
Acta Diabetologica|June 17, 2015
Prevalence of cardiovascular risk factors in youth with type 1 diabetes and elevated body mass indexMaria J Redondo, Nicole C Foster, Ingrid M Libman, et al.
Diabetes Care|December 4, 2013
Costimulation modulation with abatacept in patients with recent-onset type 1 diabetes: follow-up 1 year after cessation of treatmentTihamer Orban, Brian Bundy, Dorothy J Becker, et al.
Pediatric Diabetes|February 6, 2014
Insulin pump use in young children in the T1D Exchange clinic registry is associated with lower hemoglobin A1c levels than injection therapyScott M Blackman, Dan Raghinaru, Saleh Adi, et al.
Diabetes Care|December 19, 2015
Intranasal Glucagon for Treatment of Insulin-Induced Hypoglycemia in Adults With Type 1 Diabetes: A Randomized Crossover Noninferiority StudyMichael R Rickels, Katrina J Ruedy, Nicole C Foster, et al.
Diabetes Care|February 18, 2016
Glucagon Nasal Powder: A Promising Alternative to Intramuscular Glucagon in Youth With Type 1 DiabetesJennifer L Sherr, Katrina J Ruedy, Nicole C Foster, et al.
JAMA|February 24, 2023
Effect of Verapamil on Pancreatic Beta Cell Function in Newly Diagnosed Pediatric Type 1 Diabetes: A Randomized Clinical TrialGregory P Forlenza, Jennifer McVean, Roy W Beck, et al.
JAMA|February 24, 2023
Effect of Tight Glycemic Control on Pancreatic Beta Cell Function in Newly Diagnosed Pediatric Type 1 Diabetes: A Randomized Clinical TrialJennifer McVean, Gregory P Forlenza, Roy W Beck, et al.
Bone|February 8, 2017
Unexpected widespread hypophosphatemia and bone disease associated with elemental formula use in infants and childrenLuisa F Gonzalez Ballesteros, Nina S Ma, Rebecca J Gordon, et al.
The Lancet. Diabetes & Endocrinology|July 2, 2021
Imatinib therapy for patients with recent-onset type 1 diabetes: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trialStephen E Gitelman, Brian N Bundy, Ele Ferrannini, et al.
Diabetes Technology & Therapeutics|May 2, 2024
Multicenter Evaluation of Ultra-Rapid Lispro Insulin with Control-IQ Technology in Adults, Adolescents, and Children with Type 1 DiabetesCarol J Levy, Ryan Bailey, Lori M Laffel, et al.
Pageof 24